Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: A study of five common cancers

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 857-863

  Charvat, H ^a,b,c   Bossard, N ^a,b,c   Daubisse, L ^d,e   Binder, F ^f,g   Belot, A ^a,b,c,h   Remontet, L ^a,b,c  

^a UNIVERSITÉ LYON 1   (France)

^b LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d Registre des Cancers du Tarn   (France)

^e INSTITUT CLAUDIUS REGAUD   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g Francim Réseau français des registres des cancers   (France)

^h INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

Cancer registries; Competing risks; Crude probability; Net survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; FRANCE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER;

CANCER REGISTRIES; COMPETING RISKS; CRUDE PROBABILITY; NET SURVIVAL;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CAUSE OF DEATH; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; PROSTATIC NEOPLASMS; REGISTRIES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84888293681     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.08.006     Document Type: Article

References (25)

1. Bossard N., Velten M., Remontet L., Belot A., Maarouf N., Bouvier A.M., et al. Survival of cancer patients in France: a population-based study from the Association of the French Cancer Registries (FRANCIM). Eur J Cancer 2007, 43(1):149-160.
2. Berkson J., Gage R.P. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin 1950, 25(11):270-286.
3. Chiang C.L. Competing risks in mortality analysis. Annu Rev Public Health 1991, 12:281-307.
4. Cronin K.A., Feuer E.J. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med 2000, 19(13):1729-1740.
5. Schairer C., Mink P.J., Carroll L., Devesa S.S. Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 2004, 96(17):1311-1321.
6. Lee M., Cronin K.A., Gail M.H., Feuer E.J. Predicting the absolute risk of dying from colorectal cancer and from other causes using population-based cancer registry data. Stat Med 2012, 31(5):489-500.
7. Lambert P.C., Dickman P.W., Nelson C.P., Royston P. Estimating the crude probability of death due to cancer and other causes using relative survival models. Stat Med 2010, 29(7-8):885-895.
8. Lambert P.C., Holmberg L., Sandin F., Bray F., Linklater K.M., Purushotham A., et al. Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiol 2011, 35(6):526-533.
9. Eloranta S., Adolfsson J., Lambert P.C., Stattin P., Akre O., Andersson T.M., et al. How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden. Cancer Causes Control 2013, 24(3):505-515.
10. Gooley T.A., Leisenring W., Crowley J., Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18(6):695-706.
11. Satagopan J.M., Ben-Porat L., Berwick M., Robson M., Kutler D., Auerbach A.D. A note on competing risks in survival analysis. Br J Cancer 2004, 91(7):1229-1235.
12. Belot A., Abrahamowicz M., Remontet L., Giorgi R. Flexible modeling of competing risks in survival analysis. Stat Med 2010, 29(23):2453-2468.
13. Smith Sehdev A.E., Hutchins G.M. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med 2001, 161(2):277-284.
14. Yin D., Morris C.R., Bates J.H., German R.R. Effect of misclassified underlying cause of death on survival estimates of colon and rectal cancer. J Natl Cancer Inst 2011, 103(14):1130-1133.
15. Hinchliffe S.R., Abrams K.R., Lambert P.C. The impact of under and over-recording of cancer on death certificates in a competing risks analysis: a simulation study. Cancer Epidemiol 2013, 37(1):11-19.
16. Ederer F., Axtell L.M., Cutler S.J. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961, 6:101-121.
17. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982, 38(4):933-942.
18. Esteve J., Benhamou E., Croasdale M., Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat Med 1990, 9(5):529-538.
19. Perme M.P., Stare J., Esteve J. On estimation in relative survival. Biometrics 2012, 68(1):113-120.
20. Danieli C., Remontet L., Bossard N., Roche L., Belot A. Estimating net survival: the importance of allowing for informative censoring. Stat Med 2012, 31(8):775-786.
21. Remontet L., Bossard N., Belot A., Estève J. French network of cancer registries FRANCIM. An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies. Stat Med 2007, 26(10):2214-2228.
22. Colonna M., Bossard N., Remontet L., Grosclaude P. FRANCIM network changes in the risk of death from cancer up to five years after diagnosis in elderly patients: a study of five common cancers. Int J Cancer 2010, 127(4):924-931.
23. Daubisse-Marliac L., Delafosse P., Boitard J.B., Poncet F., Grosclaude P., Colonna M. Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Ann Oncol 2010, 22(2):329-334.
24. Fontenoy A.M., Leux C., Delacour-Billon S., Allioux C., Frenel J.S., Campone M., et al. Recent trends in breast cancer incidence rates in the Loire-Atlantique, France: a decline since 2003. Cancer Epidemiol 2010, 34(3):238-243.
25. Ramirez A.J., Westcombe A.M., Burgess S.S., Sutton S., Littlejohnsl P., Richards M.A., et al. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 1999, 353(9159):1127-1131.